Kuros Biosciences Ltd (CSBTF)
7.10
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Kuros Biosciences Shareholders Equity (Quarterly): 67.52M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 67.52M |
| June 30, 2023 | 71.13M |
| June 30, 2023 | 71.13M |
| December 31, 2022 | 74.27M |
| June 30, 2022 | 76.70M |
| June 30, 2022 | 76.70M |
| December 31, 2021 | 84.21M |
| June 30, 2021 | 92.24M |
| June 30, 2021 | 92.24M |
| December 31, 2020 | 96.83M |
| June 30, 2020 | 75.81M |
| June 30, 2020 | 75.81M |
| December 31, 2019 | 80.35M |
| June 30, 2019 | 72.87M |
| June 30, 2019 | 72.87M |
| December 31, 2018 | 77.68M |
| June 30, 2018 | 68.86M |
| June 30, 2018 | 68.86M |
| December 31, 2017 | 75.09M |
| June 30, 2017 | 81.26M |
| June 30, 2017 | 81.26M |
| December 31, 2016 | 37.66M |
| June 30, 2016 | 43.84M |
| June 30, 2016 | 43.84M |
| Date | Value |
|---|---|
| December 31, 2015 | 10.56M |
| June 30, 2015 | 1.428M |
| June 30, 2015 | 1.428M |
| December 31, 2014 | -26.52M |
| June 30, 2014 | -20.38M |
| June 30, 2014 | -20.38M |
| December 31, 2013 | 4.766M |
| September 30, 2013 | -11.44M |
| June 30, 2013 | -3.346M |
| June 30, 2013 | -3.346M |
| March 31, 2013 | 4.761M |
| December 31, 2012 | 10.57M |
| September 30, 2012 | 14.75M |
| June 30, 2012 | 20.00M |
| March 31, 2012 | -7.976M |
| December 31, 2011 | -13.01M |
| September 30, 2011 | -10.08M |
| June 30, 2011 | -3.822M |
| March 31, 2011 | 1.529M |
| December 31, 2010 | 7.055M |
| September 30, 2010 | 13.30M |
| June 30, 2010 | 17.38M |
| March 31, 2010 | 3.863M |
| December 31, 2009 | 7.958M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
67.52M
Minimum
Dec 2023
96.83M
Maximum
Dec 2020
78.71M
Average
75.81M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 191.25M |
| CRISPR Therapeutics AG | 1.883B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -4.287M |
| Molecular Partners AG | 210.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.08M |
| Total Liabilities (Quarterly) | 17.56M |
| Current Ratio | 2.062 |